However, it is clear that AhR ligands effect some AhR-dependent genes and pathways to promote mammary cancer (Figure 5), whereas there is also strong evidence that AhR agonists are potential drugs for clinical application in breast cancer therapy (Table 1, Table 2 and Table 3). This evidence concerns the gene AHR and breast cancer.